Study of a second heart valve procedure for people with a failing TAVI
Part of Heart & circulation clinical trials.
This study collects information from people who need a second heart valve placed inside a previously implanted one (called TAVI-in-TAVI). The goal is to learn more about how a specific valve (the Myval) works in this situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have already had a heart valve replacement (TAVI) at least 3 months ago.
- Your heart team has decided that you need a second valve placed inside the old one (TAVI-in-TAVI), or this has already been done.
- You are not taking part in any other interventional research trial.
- You are expected to live for more than a year and can come back for follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether the Myval THV (a new heart valve) is safe and effective for adults who need TAVI, a procedure to replace a narrowed heart valve without open-heart surgery. You may be considered if a heart team says you’re a good candidate for this valve procedure and you’re willing to join the study.
This study is tracking how well the Myval valve works in people with severe aortic stenosis who get it through a minimally invasive procedure called TAVI. It helps doctors learn more about the valve's safety and performance in real-world use.
This trial is for people who have already had a TAVI (a minimally invasive aortic valve replacement) and now need a second procedure because the valve is failing. The study will test how well a redo TAVI works to fix the failing valve.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This study looks at people who already received the Myval THV heart valve implant for severe native aortic valve narrowing. It checks how patients are doing after at least 30 days of follow-up to better understand the valve’s performance.
This trial compares two different types of replacement heart valves (balloon-expandable vs. self-expanding) to see which works better for people with severe aortic stenosis. The goal is to find the best option for each patient.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.